Human Health Holdings Past Earnings Performance
Past criteria checks 2/6
Human Health Holdings has been growing earnings at an average annual rate of 23.3%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 12.9% per year. Human Health Holdings's return on equity is 3.2%, and it has net margins of 4.1%.
Key information
23.3%
Earnings growth rate
23.2%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 12.9% |
| Return on equity | 3.2% |
| Net Margin | 4.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues
Sep 13
Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings
Jan 23Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly
Mar 21Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now
Nov 26Is Human Health Holdings (HKG:1419) Using Too Much Debt?
May 31Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)
Feb 15
Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?
Dec 25Revenue & Expenses Breakdown
How Human Health Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 591 | 24 | 184 | 0 |
| 31 Mar 24 | 603 | -22 | 192 | 0 |
| 31 Dec 23 | 616 | -67 | 199 | 0 |
| 30 Sep 23 | 809 | 57 | 205 | 0 |
| 30 Jun 23 | 1,002 | 181 | 211 | 0 |
| 31 Mar 23 | 1,208 | 367 | 201 | 0 |
| 31 Dec 22 | 1,415 | 553 | 191 | 0 |
| 30 Sep 22 | 1,268 | 464 | 179 | 0 |
| 30 Jun 22 | 1,122 | 375 | 168 | 0 |
| 31 Mar 22 | 967 | 297 | 166 | 0 |
| 31 Dec 21 | 813 | 218 | 164 | 0 |
| 30 Sep 21 | 734 | 181 | 163 | 0 |
| 30 Jun 21 | 655 | 144 | 163 | 0 |
| 31 Mar 21 | 542 | 59 | 131 | 0 |
| 31 Dec 20 | 430 | -27 | 100 | 0 |
| 30 Sep 20 | 442 | -33 | 116 | 0 |
| 30 Jun 20 | 454 | -40 | 133 | 0 |
| 31 Mar 20 | 492 | -11 | 174 | 0 |
| 31 Dec 19 | 530 | 19 | 216 | 0 |
| 30 Sep 19 | 529 | 23 | 213 | 0 |
| 30 Jun 19 | 529 | 27 | 211 | 0 |
| 31 Mar 19 | 523 | 26 | 209 | 0 |
| 31 Dec 18 | 518 | 25 | 208 | 0 |
| 30 Sep 18 | 518 | 24 | 206 | 0 |
| 30 Jun 18 | 518 | 24 | 204 | 0 |
| 31 Mar 18 | 509 | 22 | 202 | 0 |
| 31 Dec 17 | 501 | 19 | 201 | 0 |
| 30 Sep 17 | 491 | 16 | 201 | 0 |
| 30 Jun 17 | 481 | 13 | 200 | 0 |
| 31 Mar 17 | 493 | 16 | 200 | 0 |
| 31 Dec 16 | 504 | 19 | 200 | 0 |
| 30 Sep 16 | 505 | 21 | 195 | 0 |
| 30 Jun 16 | 499 | 23 | 185 | 0 |
| 30 Sep 15 | 456 | 36 | 151 | 0 |
| 30 Jun 15 | 430 | 34 | 148 | 0 |
| 30 Jun 14 | 365 | 39 | 119 | 0 |
Quality Earnings: 1419 has high quality earnings.
Growing Profit Margin: 1419's current net profit margins (4.1%) are lower than last year (18.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1419's earnings have grown significantly by 23.3% per year over the past 5 years.
Accelerating Growth: 1419's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1419 had negative earnings growth (-86.6%) over the past year, making it difficult to compare to the Healthcare industry average (-16.9%).
Return on Equity
High ROE: 1419's Return on Equity (3.2%) is considered low.